Organon & Co (OGN)
Healthcare
Drug Manufacturers - General
13.60 $
+0.0%
vs. previous close
Closing price · As of: 31. Jul 2026
Dividend history for Organon & Co (OGN): every payment, yield, payout ratio and growth at a glance. The most recent distribution was 0.0200 $ per share (ex-date 05/11/2026).
Dividend
Dividend Yield
Annual dividend divided by the current price: what percentage of your investment comes back as a payout each year.
0.59%
Dividend Per Share (TTM)
Sum of dividends paid per share over the last 12 months.
0.08$
Payout Ratio
Share of profit paid out as dividends. Over 100% means the company is paying out more than it earns — not sustainable long-term.
2.4%
Increase Streak
How many years in a row the dividend has been raised — the gold standard for dividend payers.
0Years
Years Without a Cut
How many years in a row the dividend hasn't been cut — a measure of reliability.
0Years
Payment History
| Ex-Date | Payment Date | Amount | Type |
|---|---|---|---|
| 08/14/2026 announced | 09/10/2026 | 0.0200 $ | Quarterly |
| 05/11/2026 | 06/11/2026 | 0.0200 $ | Quarterly |
| 02/23/2026 | 03/12/2026 | 0.0200 $ | Quarterly |
| 11/20/2025 | 12/11/2025 | 0.0200 $ | Quarterly |
| 08/15/2025 | 09/11/2025 | 0.0200 $ | Quarterly |
| 05/12/2025 | 06/12/2025 | 0.0200 $ | Quarterly |
| 02/24/2025 | 03/13/2025 | 0.28 $ | Quarterly |
| 11/12/2024 | 12/12/2024 | 0.28 $ | Quarterly |
| 08/16/2024 | 09/12/2024 | 0.28 $ | Quarterly |
| 05/10/2024 | 06/13/2024 | 0.28 $ | Quarterly |
| 02/23/2024 | 03/14/2024 | 0.28 $ | Quarterly |
| 11/10/2023 | 12/14/2023 | 0.28 $ | Quarterly |
| 08/17/2023 | 09/14/2023 | 0.28 $ | Quarterly |
| 05/12/2023 | 06/15/2023 | 0.28 $ | Quarterly |
| 02/24/2023 | 03/16/2023 | 0.28 $ | Quarterly |
| 11/10/2022 | 12/15/2022 | 0.28 $ | Quarterly |
| 08/12/2022 | 09/15/2022 | 0.28 $ | Quarterly |
| 05/13/2022 | 06/16/2022 | 0.28 $ | Quarterly |
| 02/25/2022 | 03/17/2022 | 0.28 $ | Quarterly |
| 11/19/2021 | 12/16/2021 | 0.28 $ | Quarterly |
| 08/20/2021 | 09/13/2021 | 0.28 $ | Quarterly |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.